AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Corteva's Viatude fungicide offers preventive and curative action on white mold to reduce disease infection.
Evogene Ltd. (NASDAQ: EVGN), a leading computational biology company, has announced its financial results for the first quarter of 2025. The company reported total revenues of approximately $2.4 million, a decrease from $4.2 million in the first quarter of 2024. The primary driver of revenue in the first quarter of 2025 was an increase in seed sales by Casterra.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet